2,869
Views
0
CrossRef citations to date
0
Altmetric
Editorial

From Personalized Medicine to Personalized Justice: The Promises of Translational Pharmacogenomics in the Justice System

, , , , , , , , , , , , , , , & show all
Pages 731-737 | Published online: 27 May 2010

Bibliography

  • Miller ED : A bold leap into the future – personalized medicine is key to the new genes to society curriculum. In: Hopkins Medicine. Pasquale SE (Ed.). Johns Hopkins Medicine, Baltimore, MD, USA, 48 (2009).
  • Wu AHB , BabicN, YeoKTJ: Implementation of pharmacogenomics into the clinical practice of therapeutics: issues for the clinician and the laboratorian.Per. Med.6 , 315–327 (2009).
  • Wadelius M , PirmohamedM: Pharmacogenetics of warfarin: current status and future challenges.Pharmacogenomics J.8(7) , 99–111 (2007).
  • Ray T : FDA updates warfarin labeling with PGx-guided dosing ranges. Pharmacogenomics Reporter 3 February 2010.
  • Wong SH : Pharmacogenomics and personalized medicine for drug addiction and toxicology: towards personalized justice? Presented at: 11th Asian Pacific Congress of Clinical Biochemistry. Beijing, China, 14–19 October 2007.
  • Wong SHY , HappyC: Personalized justice, translational pharmacogenomics and personalized medicine – relevant to the forensic sciences?Tox. Talk33 , 22–23 (2009).
  • Wong SH , JM Jentzen, RZ Shi; the Forensic Pathology/Toxicology Methadone Pharmacogenomics Study Group (FPTMPGxSG): Personalized medicine enabling personalized justice: methadone pharmacogenomics as an adjunct – for molecular autopsy, and for addiction and driving under the influence of drugs (DUID). Clin. Chem. Lab. Med.46 , A118 (2008).
  • Wong SHY : Pharmacogenomics as molecular autopsy – an adjunct to forensic pathology/toxicology: from Gregor Mendel to personalized medicine and personalized justice. In: Clarke‘s Analysis of Drugs and Poisons (4th Edition). Moffat AC, Osselton DM, Widdop B (Eds). Royal Pharmaceutical Society Publishing, London, UK (2010) (In Press).
  • Jeffreys AJ , WilsonV, TheinSL: Individual-specific ‘fingerprints‘ of human DNA.Nature316(6023) , 76–79 (1985).
  • Sallee FR , DeVaneCL, FerrellRE: Fluoxetine-related death in a child with cytochrome P-450 2D6 genetic deficiency.J. Child. Adolesc. Psychopharmacol.10 , 327–334 (2000).
  • Cote JF , KirzinS, KramarA et al.: UGT1A1 polymorphism can predict hematologic toxicigy inpatients treated with irinotecan.Clin. Cancer Res.13 , 3269–3275 (2007).
  • Mallal S , PhillipsE, CarosiG et al.: HLA-B*5701 screening for hypersensitivity to abacavir.N. Engl. J. Med.358 , 568–579 (2008).
  • Chung WH , HungSI, HongHS et al.: Medical genetics: a marker for Stevens–Johnson syndrome.Nature428 , 486 (2004).
  • Committee on Identifying the Needs of the Forensic Science Community – National Research Council of the National Academies: Strengthening Forensic Science in the United States: A Path Forward. National Academy of Sciences. The National Academies Press, Washington, DC, USA, 1–352 (2009).
  • American Academy of Forensic Sciences: The American Academy of Forensic Sciences approved position statement in response to National Academy of Sciences‘ “Forensic Needs” Report. American Academy Of Forensic Sciences, CO, USA (2009).
  • Bohan TL : President‘s message.Academy News39(1) , 34–35 (2009).
  • Gianelli P : Understanding Evidence (3rd Edition). 323 (2003).
  • Federal Judicial Center: Reference Manual on Scientific Evidence (2nd Edition). Washington, DC, USA, 487 (2000).
  • Federal Rule of Evidence, 702, Testimony by Experts.
  • Kassirer JP , CecilJS: Inconsistency in evidentiary standards for medical testimony: disorder in the courts.JAMA288 , 1382–1387 (2002).
  • Penry v. Lynaugh, 429 US 302 (1989).
  • Roper v. Simmons, 543 US 551 (2005).
  • Atkins v. Virginia, 536 US 304 (2002).
  • Wong SHY , WagnerMA, JentzenJM et al.: Pharmacogenomics as an adjunct of molecular autopsy for forensic pathology/toxicology: does genotyping CYP 2D6 serve as an adjunct for certifying methadone toxicity?J. Forensic Sci.48 , 1406–1415 (2003).
  • Wong SHY , GockSB, ShiRZ et al.: Pharmacogenomics as an aspect of molecular autopsy for forensic pathology/toxicology. In: Pharmacogenomics and Proteomics: Enabling the Practice of Personalized Medicine. Wong SHY, Linder M, Valdes R Jr (Eds). AACC Press, Washington, DC, USA, 311–320 (2006).
  • Molina DK : Handbook of Forensic Toxicology for Medical Examiners. CRC Press, Boca Raton, FL, USA, 1–370 (2010) (Appendix C – PGXs, 343–347).
  • Karch SB : Karch‘s Pathology of Drug Abuse (4th Edition). CRC Press, Boca Raton, FL, USA, 1–709 (2009).
  • Ernst C , MechawarN, TureckiG: Suicide neurobiology.Prog. Neurobiol.89 , 315–333 (2009).
  • Golgin E : Epigenetic suicide note. The Scientist, 18–19 August (2009).
  • Kim S , MisraA: SNP genotyping technologies and biomedical applications.Annu. Rev. Biomed. Eng.9 , 289–320 (2007).
  • Neuman MG , MalkiewiczIM, ShearNH: A novel lymphocyte toxicity assay to assess drug hypersensitivity syndromes.Clin. Biochem.33 , 517–524 (2000).
  • King AC , VolpicelliJR, FrazerA, O‘BrienCP: Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence.Psychopharmacology129 , 15–22 (1997).
  • Wang JB , ImaiY, EpplerCM, GregorP, SpivakCE, UhlGR: µ-opiate receptor: cDNA cloning and expression.Proc. Natl Acad. Sci. USA90(21) , 10230–10234 (1993).
  • Healy D , HerxheimerA, MenkesDB: Antidepressants and violence: problems at the interface of medicine and law.PloS3 , 1478–1487 (2006).
  • Stehle S , KirchheinerU, LazarA, FuhrU: PGXs of oral anticoagulants.Clin. Pharmacokin.47 , 565–594 (2008).
  • Kangelaris KN , BentS, NussbaumRL, GarciaDA, TiceJA: Genetic testing before anticoagulation? A systematic review of PGX dosing of warfarin.J. Gen. Intern. Med.24 , 656–664 (2009).
  • Caldwell MD , AwadT, JohnsonJA et al.: CYP4F2 genetic variant alters required warfarin dose.Blood111 , 4106–4112 (2008).
  • Gage BF , EbyC, JohnsonJA et al.: Use of PGX and clinical factors to predict the therapeutic dose of warfarin.Clin. Pharmacol. Ther.84 , 326–331 (2008).
  • Woodcock J : A difficult balance – pain management, drug safety and the FDA.N. Engl. J. Med.361 , 2105–2107 (2009).
  • Madadi P , KorenG, CairnsJ et al.: Safety of codeine during breastfeeding: fatal morphine poisoning in the breastfed neonate of a mother prescribed codeine.Can. Fam. Phys.53 , 33–35 (2007).
  • Bosker WM , HuestisMA: Oral fluid testing for drugs of abuse.Clin. Chem.55 , 1910–1931 (2009).
  • Cone EJ , HuestisMA: Interpretation of oral fluid tests for drugs of abuse.Ann. NY Acad. Sci.1098 , 51–103 (2007).
  • Pil K , VerstraeteAZ: Current developments in drug testing in oral fluids.Ther. Drug Monit.30 , 196–202 (2008).
  • Bush DM : The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.Forensic Sci. Int.174 , 111–119 (2008).

▪ Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.